173 related articles for article (PubMed ID: 17928089)
1. Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres.
Varde NK; Pack DW
J Control Release; 2007 Dec; 124(3):172-80. PubMed ID: 17928089
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
Kang J; Schwendeman SP
Biomaterials; 2002 Jan; 23(1):239-45. PubMed ID: 11762843
[TBL] [Abstract][Full Text] [Related]
4. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.
del Barrio GG; Novo FJ; Irache JM
J Control Release; 2003 Jan; 86(1):123-30. PubMed ID: 12490378
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
Walter E; Moelling K; Pavlovic J; Merkle HP
J Control Release; 1999 Sep; 61(3):361-74. PubMed ID: 10477808
[TBL] [Abstract][Full Text] [Related]
8. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
[TBL] [Abstract][Full Text] [Related]
9. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Nov; 22(7):705-14. PubMed ID: 16421082
[TBL] [Abstract][Full Text] [Related]
10. Electrospray synthesis and properties of hierarchically structured PLGA TIPS microspheres for use as controlled release technologies.
Malik SA; Ng WH; Bowen J; Tang J; Gomez A; Kenyon AJ; Day RM
J Colloid Interface Sci; 2016 Apr; 467():220-229. PubMed ID: 26803601
[TBL] [Abstract][Full Text] [Related]
11. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.
Wang D; Robinson DR; Kwon GS; Samuel J
J Control Release; 1999 Jan; 57(1):9-18. PubMed ID: 9863034
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
Cirpanli Y; Unlü N; Caliş S; Hincal AA
J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
Wu XS
Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
[TBL] [Abstract][Full Text] [Related]
15. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
16. Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis.
Jiang T; Petersen RR; Call G; Ofek G; Gao J; Yao JQ
J Biomed Mater Res B Appl Biomater; 2011 May; 97(2):355-63. PubMed ID: 21442745
[TBL] [Abstract][Full Text] [Related]
17. Injectable and porous PLGA microspheres that form highly porous scaffolds at body temperature.
Qutachi O; Vetsch JR; Gill D; Cox H; Scurr DJ; Hofmann S; Müller R; Quirk RA; Shakesheff KM; Rahman CV
Acta Biomater; 2014 Dec; 10(12):5090-5098. PubMed ID: 25152354
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
